{"DataElement":{"publicId":"2956045","version":"1","preferredName":"Person Plasma Cell Myeloma Stage Grouping Clinical Trial Eligibility Criteria Stage","preferredDefinition":"an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage of multiple myeloma (cancer that arises in plasma cells ) for eligibility criteria.","longName":"2956042v1.0:2956043v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2956042","version":"1","preferredName":"Person Plasma Cell Myeloma Stage Grouping Clinical Trial Eligibility Criteria","preferredDefinition":"information related to the an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage of multiple myeloma (cancer that arises in plasma cells ).","longName":"2236731v1.0:2956040v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2956040","version":"1","preferredName":"Myeloma Stage Grouping Clinical Trial Eligibility Criteria","preferredDefinition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001) -- 2003:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR):Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C3242:C38027:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Myeloma","conceptCode":"C3242","definition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76DBFAB1-C76C-954C-E040-BB89AD4346D1","latestVersionIndicator":"Yes","beginDate":"2009-10-26","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-10-26","modifiedBy":"ONEDATA","dateModified":"2009-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76DBFAB1-C77D-954C-E040-BB89AD4346D1","latestVersionIndicator":"Yes","beginDate":"2009-10-26","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-10-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2956043","version":"1","preferredName":"Plasma Cell Myeloma Stage Grouping Clinical Trial Eligibility Criteria Stage","preferredDefinition":"the extent of multiple myeloma within the body for eligibility criteria.","longName":"2956043v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage I","valueDescription":"Stage I","ValueMeaning":{"publicId":"2565870","version":"1","preferredName":"Stage I","longName":"2565870v1.00","preferredDefinition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I","conceptCode":"C27966","definition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CE5B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-04-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-04-16","modifiedBy":"KUMMEROA","dateModified":"2023-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76DBFAB1-C7A3-954C-E040-BB89AD4346D1","beginDate":"2009-10-26","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-10-26","modifiedBy":"ONEDATA","dateModified":"2009-10-26","deletedIndicator":"No"},{"value":"Stage II","valueDescription":"Stage II","ValueMeaning":{"publicId":"2565874","version":"1","preferredName":"Stage II","longName":"2565874v1.00","preferredDefinition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II","conceptCode":"C28054","definition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CE5F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-04-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-04-21","modifiedBy":"KUMMEROA","dateModified":"2023-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76DBFAB1-C7AE-954C-E040-BB89AD4346D1","beginDate":"2009-10-26","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-10-26","modifiedBy":"ONEDATA","dateModified":"2009-10-26","deletedIndicator":"No"},{"value":"Stage III","valueDescription":"Stage III","ValueMeaning":{"publicId":"2565875","version":"1","preferredName":"Stage III","longName":"2565875v1.00","preferredDefinition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III","conceptCode":"C27970","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CE60-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-04-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-04-21","modifiedBy":"KUMMEROA","dateModified":"2023-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76DBFAB1-C7B9-954C-E040-BB89AD4346D1","beginDate":"2009-10-26","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-10-26","modifiedBy":"ONEDATA","dateModified":"2009-10-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76DBFAB1-C78E-954C-E040-BB89AD4346D1","latestVersionIndicator":"Yes","beginDate":"2009-10-26","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-10-26","modifiedBy":"ALAIS","dateModified":"2009-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is the patient's current","type":"Preferred Question Text","description":"What is the patient's current disease status","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"76DBFAB1-C7C4-954C-E040-BB89AD4346D1","latestVersionIndicator":"Yes","beginDate":"2009-10-26","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-10-26","modifiedBy":"ALAIS","dateModified":"2009-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}